BmLAO-f1

General Information


DRACP ID  DRACP03472

Peptide Name   BmLAO-f1

Sequence  IKFEPPLPPKKAH

Sequence Length  13

UniProt ID  B3EWI9 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03472

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C73H116N18O16

Absent amino acids  CDGMNQRSTVWY

Common amino acids  P

Mass  171605

Pl  10.51

Basic residues  4

Acidic residues  1

Hydrophobic residues  4

Net charge  3

Boman Index  -1349

Hydrophobicity  -91.54

Aliphatic Index  67.69

Half Life 
  Mammalian: 1.9 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22438972

Title  Evaluation of an antimicrobial L-amino acid oxidase and peptide derivatives from Bothropoides mattogrosensis pitviper venom

Doi Not available

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  4693

DRACP is developed by Dr.Zheng's team.